Skip to main content
XBIO logo

Xenetic Biosciences, Inc.

XBIONASDAQHealthcareBiotechnology

$1.85Today:- (-)1Y −50.78%

As of Oct 26, 2026 close

Market cap
$4.24M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.85$4.94
Volume (live)
-
Avg. volume (3M)
118.58K

Xenetic Biosciences (XBIO) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Xenetic Biosciences reported total assets of $8.36M and total liabilities of $968.02K. Shareholders' equity was $7.40M, up 23.1% from $6.01M a year earlier. Total debt stood at $0.00 against $7.88M in cash and short-term investments, a net cash position of $7.88M. That puts debt-to-equity at 0.00, compared with 0.00 a year earlier.

Xenetic Biosciences Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Xenetic Biosciences, Inc. (XBIO) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Mar 2019Dec 2017
Current Assets
Cash and Cash Equivalents7.886.178.9813.1018.2411.5310.370.575.53
Cash & Short-Term Investments7.886.178.9813.1018.2411.5310.370.575.53
Accounts Receivable0.000.000.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.000.000.00
Other Current Assets0.170.420.600.560.480.840.720.620.35
Total Current Assets8.056.599.5913.6518.7212.3711.091.195.88
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.000.000.030.020.000.03
Goodwill0.000.000.000.000.000.000.003.283.28
Intangible Assets0.000.000.000.000.000.009.249.249.24
Other Non-Current Assets0.310.311.021.071.090.681.190.710.72
Total Non-Current Assets0.310.311.021.071.090.8110.4613.2413.28
Total Assets8.366.9010.6114.7219.8213.1821.5514.4319.16
Current Liabilities
Accounts Payable0.260.280.240.290.360.330.930.930.79
Short-Term Debt0.000.000.000.000.030.040.020.000.00
Accrued Liabilities0.690.610.570.790.990.57---
Other Current Liabilities0.020.030.570.791.030.570.460.671.16
Total Current Liabilities0.970.890.811.071.420.941.421.601.94
Non-Current Liabilities
Long-Term Debt0.000.000.000.000.000.030.000.000.00
Deferred Tax Liabilities0.000.000.000.000.000.002.922.922.92
Other Non-Current Liabilities0.000.000.000.000.000.000.000.000.00
Total Non-Current Liabilities0.000.000.000.000.000.032.922.922.92
Total Liabilities0.970.890.811.071.420.964.334.524.86
Stockholders' Equity
Common Stock0.000.000.000.000.010.010.010.010.01
Retained Earnings-199.88-197.19-193.23-189.10-182.55-176.90-166.01-153.23-145.93
Accumulated Other Comprehensive Income0.250.250.250.250.250.250.250.250.25
Treasury Stock5.285.285.285.285.28----
Additional Paid-in Capital212.29208.23202.77202.49200.67188.85182.96162.88159.97
Shares Outstanding2.291.541.541.521.34----
Total Stockholders' Equity7.406.019.8013.6518.3912.2217.219.9114.30
Total Liabilities & Equity8.366.9010.6114.7219.8213.1821.5514.4319.16

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Xenetic Biosciences Balance Sheet

How much debt does Xenetic Biosciences have?

Xenetic Biosciences had total debt of $0.00 as of Dec 31, 2025, against $7.88M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $0.00 a year earlier.

What are Xenetic Biosciences's total assets?

Xenetic Biosciences reported total assets of $8.36M as of Dec 31, 2025, up 21.2% from $6.90M a year earlier. Total liabilities were $968.02K.

What is Xenetic Biosciences's shareholders' equity?

Xenetic Biosciences's shareholders' equity was $7.40M as of Dec 31, 2025, or about $3.23 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition